| Nicole Irene Hunter, APRN CNM | |
|
3033 Excelsior Blvd Ste 585, Minneapolis, MN 55416-6400 | |
| (612) 345-5920 | |
| (844) 562-6828 |
| Full Name | Nicole Irene Hunter |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 3033 Excelsior Blvd Ste 585, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326534108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | R1578311 (Minnesota) | Primary |
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
The Associated Press/ABC news explore the question of how of cost containment under the new health law: "What's it going to cost me? That's the single biggest unanswered question about President Barack Obama's new health care overhaul law — and its weak spot. Many experts believe the law falls short on taming costs, and that will force Congress to revisit health care in a few years. … For now, the political parties are too polarized — and lawmakers too exhausted — to contemplate health care 2.0.
For the first time ever, clinicians have the flexibility to track X-ray skin dose exposure in real time during interventional procedures with Toshiba America Medical Systems, Inc.'s Dose Tracking System. FDA cleared on Toshiba's InfinixTM-i cardiovascular X-ray systems for use in pediatric and adult cardiac and abdominal procedures, the new technology is Toshiba's latest advancement in optimizing dose management to improve patient safety.
The European Chronic Disease Alliance (ECDA) welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world biggest killers. "It is a memorable day in the history of public health. Discussing non communicable diseases at the UN table gives a strong sense of the burden it represents to human kind and the recognition that NCDs is a challenge for all nations in the world", declared Professor Michel Komajda, President of the European Society of Cardiology, an active member of the ECDA.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
› Verified 1 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
The Associated Press/ABC news explore the question of how of cost containment under the new health law: "What's it going to cost me? That's the single biggest unanswered question about President Barack Obama's new health care overhaul law — and its weak spot. Many experts believe the law falls short on taming costs, and that will force Congress to revisit health care in a few years. … For now, the political parties are too polarized — and lawmakers too exhausted — to contemplate health care 2.0.
For the first time ever, clinicians have the flexibility to track X-ray skin dose exposure in real time during interventional procedures with Toshiba America Medical Systems, Inc.'s Dose Tracking System. FDA cleared on Toshiba's InfinixTM-i cardiovascular X-ray systems for use in pediatric and adult cardiac and abdominal procedures, the new technology is Toshiba's latest advancement in optimizing dose management to improve patient safety.
The European Chronic Disease Alliance (ECDA) welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world biggest killers. "It is a memorable day in the history of public health. Discussing non communicable diseases at the UN table gives a strong sense of the burden it represents to human kind and the recognition that NCDs is a challenge for all nations in the world", declared Professor Michel Komajda, President of the European Society of Cardiology, an active member of the ECDA.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Irene Hunter, APRN CNM 3033 Excelsior Blvd Ste 585, Minneapolis, MN 55416-6400 Ph: (612) 345-5920 | Nicole Irene Hunter, APRN CNM 3033 Excelsior Blvd Ste 585, Minneapolis, MN 55416-6400 Ph: (612) 345-5920 |
News Archive
The Associated Press/ABC news explore the question of how of cost containment under the new health law: "What's it going to cost me? That's the single biggest unanswered question about President Barack Obama's new health care overhaul law — and its weak spot. Many experts believe the law falls short on taming costs, and that will force Congress to revisit health care in a few years. … For now, the political parties are too polarized — and lawmakers too exhausted — to contemplate health care 2.0.
For the first time ever, clinicians have the flexibility to track X-ray skin dose exposure in real time during interventional procedures with Toshiba America Medical Systems, Inc.'s Dose Tracking System. FDA cleared on Toshiba's InfinixTM-i cardiovascular X-ray systems for use in pediatric and adult cardiac and abdominal procedures, the new technology is Toshiba's latest advancement in optimizing dose management to improve patient safety.
The European Chronic Disease Alliance (ECDA) welcomes the UN High Level Meeting on Non Communicable Diseases (NCDs) to address the world biggest killers. "It is a memorable day in the history of public health. Discussing non communicable diseases at the UN table gives a strong sense of the burden it represents to human kind and the recognition that NCDs is a challenge for all nations in the world", declared Professor Michel Komajda, President of the European Society of Cardiology, an active member of the ECDA.
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
› Verified 1 days ago
Claire C Nelson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 | |
Pamela S.f. Glenn, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1200 Lagoon Ave, Minneapolis, MN 55408 Phone: 612-823-6300 | |
Susanna Goldstein, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3033 Excelsior Blvd, Minneapolis, MN 55416 Phone: 612-345-5920 | |
Heather Christopher, APRN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2606 Chicago Ave, Minneapolis, MN 55407 Phone: 612-545-5311 | |
Olivia Lynn Fricke, CNM, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1919 Nicollet Ave, Minneapolis, MN 55403 Phone: 719-580-9134 Fax: 612-236-4745 | |
Julia M Cross, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 | |
Nancy L Schamber, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 |